Effect of Paclitaxel on Platelet Aggregation Induced by Adenosine Diphosphate in vitro

ZHANG Shu,  SUN Chang-li,  NIE Hu; ZHANG Shu,  SUN Chang-li,  NIE Hu

Paper Submission

Effect of Paclitaxel on Platelet Aggregation Induced by Adenosine Diphosphate in vitro

ZHANG Shu, SUN Chang-li, NIE Hu

Abstract

To investigate the effect of paclitaxel on platelet aggregation induced by adenosine diphosphate (ADP) in vitro. Methods Platelet suspension was incubated with paclitaxel in different concentrations（0 ng/mL, 0.01 ng/mL, 0.1 ng/mL, 1 ng/mL, 10 ng/mL, 100 ng/mL, 1 000 ng/mL）, then the maximal extent of platelet aggregation was determined under the conditions of the best ADP concentration and the best incubation time. Results Under the condition of 10 μmol/L ADP and incubated for 10 min, with the increase of paclitaxel concentration, the effect of paclitaxel on platelet aggregation induced by ADP elevated accordingly，and the differences among the different concentration groups were statistically significant (Pin vitro.

Keywords: Paclitaxel, Adenosine diphosphate, Platelet aggregation

Full Text:

PDF

References

Shishehbor MH. Goel SS, Kapadia SR. et al. Long-term impact of drug-eluting stents versus bare-metal stents on all-cause mortality. J Am Coll Cardiol,2008;52(13): 1041-1048.

Steffel J. Eberli FR, Luscher TF. et al. Drug-eluting stents - what should be improved? Ann Med.2008;40(4) ;242-252.

Joner M. Finn AV. Farb A, et al. Pathology of drug-eluting stents in humans; delayed healing and late thrombotic risk. J Am Coll Cardiol,2006;48( 1); 193-202.

Virmani R, Guagliumi G, Farb A, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation, 2004;109(6);701-705.

Finn AV, Joner M, Nakazawa G, et al. Pathological correlates of late drug-eluting stent thrombosis; strut coverage as a marker of endothelialization. Circulation,2007 ; 115(18); 2435-2441.